Share on StockTwits

Curis (NASDAQ:CRIS) is scheduled to be announcing its Q214 earnings results on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $3.46 million for the quarter.

Curis (NASDAQ:CRIS) opened at 1.84 on Wednesday. Curis has a 52 week low of $1.60 and a 52 week high of $4.74. The stock has a 50-day moving average of $1. and a 200-day moving average of $2.33. The company’s market cap is $158.1 million.

CRIS has been the subject of a number of recent research reports. Analysts at Zacks upgraded shares of Curis from a “neutral” rating to an “outperform” rating in a research note on Wednesday, July 9th. They now have a $2.10 price target on the stock. Analysts at Oppenheimer cut their price target on shares of Curis from $4.50 to $3.00 in a research note on Friday, May 9th. They now have an “outperform” rating on the stock. They noted that the move was a valuation call. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $4.92.

Curis, Inc is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.